Login to Your Account

Pharmexa's $18M Not Enough to Secure Company's Future

By Cormac Sheridan

Wednesday, February 6, 2008
The management of Pharmexa A/S is starting to scout around for whatever "strategic alternatives" may be available to the company, following the completion of a rights issue that grossed DKK91.2 million (US$18 million). (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription